India's bioeconomy surged from $10 billion in 2014 to $166 billion by 2026, marking a 16-fold growth over the decade. The market is distributed across Bio-Industrial (47%), Bio-Pharma (35%), Bio-Research & IT (9%), and Bio-Agri (8%). The sector is supported by over 11,800 biotech startups across the country.

India supplies 65% of WHO's vaccine requirements. The Ethanol Blending Programme achieved its 20% (E20) target in 2025, five years ahead of schedule. A new BSL-4 bio-containment facility is being developed in Gandhinagar, Gujarat, under the Gujarat State Biotechnology Mission, alongside the existing facility at NIV Pune. This positions India as a major global bioeconomy player.